Availability, price and affordability of cardiovascular medicines: <it>A comparison across 36 countries using WHO/HAI data</it>
<p>Abstract</p> <p>Background</p> <p>The global burden of cardiovascular disease (CVD) continues to rise. Successful treatment of CVD requires adequate pharmaceutical management. The aim was to examine the availability, pricing and affordability of cardiovascular medici...
Main Authors: | Cameron Alexandra, van Mourik Maaike SM, Ewen Marg, Laing Richard O |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-06-01
|
Series: | BMC Cardiovascular Disorders |
Online Access: | http://www.biomedcentral.com/1471-2261/10/25 |
Similar Items
-
Access to Essential Cardiovascular Medicines in Pakistan: A National Survey on the Availability, Price, and Affordability, Using WHO/HAI Methodology
by: Amna Saeed, et al.
Published: (2021-01-01) -
Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology
by: Mekonnen Sisay, et al.
Published: (2021-07-01) -
Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology
by: Amare, F., et al.
Published: (2021) -
Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
by: Amna Saeed, et al.
Published: (2019-01-01) -
Survey and analysis of the availability and affordability of essential drugs in Hefei based on WHO / HAI standard survey methods
by: Zuojun Dong, et al.
Published: (2020-09-01)